Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.1.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
N/AENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.109ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.361ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.417ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.319ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.182ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.430ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.331ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.112.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
N.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.515ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.287ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.431ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.170ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.506ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.6.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.438.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.188ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.494ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.167ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.267ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.165ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.554ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.243.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.450ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.130ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.444ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.268ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.344ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.103ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.485ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.119ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.276ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.111ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used